Latest news with #S&P500Composite
Yahoo
11 hours ago
- Business
- Yahoo
TOST Stock Rises 19% in Three Months: Time to Hold or Make an Exit?
Toast, Inc. TOST shares have gained 19.2% in the past three months, outperforming the Internet Software market and the Zacks Computer & Technology sector's growth of 12.5% and 9.7%, respectively. The S&P 500 Composite has returned 5.3% over the same time frame. TOST is one of the leading providers of software-as-a-service (SaaS) and hardware solutions focused on the restaurant market. Image Source: Zacks Investment Research TOST declined 2.4% last day and closed the session at $41.54, close to its 52-week high of $45.56. While the recent momentum may seem encouraging, let's take a closer look at the company's pros and cons to ascertain whether investors hold the stock or exit the investment. Heightened uncertainty prevailing over the macro environment amid escalating trade war, with tariff troubles raising fears of increased costs and dampening consumer purchasing power, remains a concern. Higher tariffs can lead to a reduction in profit for the average independent restaurant operator. Management highlighted that it was closely monitoring the macro environment and emphasized restaurants' ability to navigate macro challenges. Despite Toast's confidence, the restaurant industry is still highly sensitive to consumer spending, labor inflation and supply chain volatility. A consumer downturn or cost pressures could reduce restaurant spend on technology, thereby impacting TOST's performance. Toast, Inc. price-consensus-eps-surprise-chart | Toast, Inc. Quote Decline in Gross Payment Volume or GPV per location is another problem, as it implies lower average transaction volumes. TOST's overall GPV surged 22% year over year to $42 billion in the first quarter, but GPV per location declined 3% year over year. TOST added that it expects GPV per location to remain down in a similar range in the current quarter. Image Source: Zacks Investment Research Higher costs can weigh on profitability. In the last reported quarter, operating expenses, excluding bad debt and credit-related expenses, increased 12%. Sales & marketing expenses grew 25% year over year due to higher headcount and brand marketing investments across core, retail and international segments. Higher costs can prove a drag on margins, especially if revenue growth does not keep pace. Although Toast emphasized progress in the international, retail and enterprise verticals, the investment in these nascent areas could take time to scale and may drag on margins in the near term if costs outpace revenue contribution. TOST needs to watch out for the competitive pressure from various small and big players who are also vying for a larger share of this lucrative market. Block XYZ, Oracle ORCL, and Lightspeed LSPD compete in varying degrees with Toast, though each company approaches the market differently. Tech behemoth Oracle offers a wide range of products, including POS systems like Oracle Retail Xstore and Oracle MICROS Simphony POS. MICROS Simphony targets large restaurant chains, hotels, casinos, and resorts. Lightspeed provides a one-stop commerce platform for merchants and serves retail, hospitality and golf businesses. It offers a cloud solution that transforms and combines online and physical operations, multichannel sales and aids in expansion to new locations. It also facilitates global payments, financing and connection to supplier networks. Block, formerly known as Square, offers financial and marketing services through its comprehensive commerce ecosystem that helps sellers to start, run and grow their businesses. Block's Square for Restaurants POS platform competes directly with TOST's offerings. TOST stock is also not so cheap, as its Value Style Score of F suggests a stretched valuation at this moment. Image Source: Zacks Investment Research TOST is quite expensive, with the stock trading at a premium with a price/book multiple of 12.35X compared with the industry's 6.26X. Toast faces several challenges, like an uncertain macro environment, competitive threats and stretched valuation. These concerns suggest that the recent rally over the past three months provides a strategic opportunity to exit before macroeconomic headwinds or company-specific issues wipe out returns. With a Zacks Rank #4 (Sell), investors would be better off if they offloaded this stock from their portfolios. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Oracle Corporation (ORCL) : Free Stock Analysis Report Lightspeed Commerce Inc. (LSPD) : Free Stock Analysis Report Toast, Inc. (TOST) : Free Stock Analysis Report Block, Inc. (XYZ) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
Yahoo
06-06-2025
- Business
- Yahoo
Here's Why You Must Add National Grid Stock to Your Portfolio Now
National Grid NGG stands to benefit from its strategic investment in infrastructure upgrades and expansion. Rising demand from new customer connections, along with its low-risk, high-quality assets, makes NGG an attractive investment opportunity in the Zacks Utility Electric Power us focus on the factors that make this Zacks Rank #2 (Buy) company a strong investment pick at the moment. The Zacks Consensus Estimate for NGG's fiscal 2026 earnings per share (EPS) has increased 2.7% to $4.94 in the past 30 company's (three to five years) earnings growth rate is pegged at 2.3%. NGG has been consistently increasing shareholders' value by paying dividends. The company's current dividend yield is 5.73%, up from the S&P 500 Composite's 1.24%. National Grid has plans to invest nearly $69 billion (£60 billion) across its service territory in the United Kingdom and the United States over the next five company will benefit from increased demand resulting from new customer connections in its service zone. In total, 2.5 gigawatts (GW) of customer projects were connected to the transmission network this year, with 1.6 GW being renewables. National Grid's current ratio at the end of fiscal 2025 was 1.35, higher than the industry's average of 0.93. The ratio being greater than one indicates the company's ability to meet its future short-term liabilities without difficulties. National Grid's times interest earned ratio (TIE) at the end of fiscal 2025 was 3. The strong TIE ratio indicates that the company will be able to meet its interest payment obligations in the near term without any problems. The company is enabling the energy transition for all and intends to achieve net-zero emissions by 2050. National Grid works together with its partners to speed up the transition to a clean energy future. In the United States, NGG has made considerable investments in large-scale renewable energy projects such as wind and solar. In the past six months, NGG shares have risen 15.3% compared with its industry's growth of 3.9%. Image Source: Zacks Investment Research A few other top-ranked stocks related to the same industry are Evergy, Inc. EVRG, NiSource Inc. NI and CenterPoint Energy CNP, each holding a Zacks Rank #2 at present. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks long-term earnings growth rate is 5.7%. The Zacks Consensus Estimate for 2025 EPS is pegged at $4.03, which indicates a year-over-year improvement of 5.8%. NI's long-term earnings growth rate is 7.9%. The Zacks Consensus Estimate for 2025 EPS is pegged at $1.88, which suggests a year-over-year rise of 7.4%. CNP's long-term earnings growth rate is 7.8%. The Zacks Consensus Estimate for 2025 EPS is pegged at $1.75, which calls for a year-over-year improvement of 8%. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report NiSource, Inc (NI) : Free Stock Analysis Report CenterPoint Energy, Inc. (CNP) : Free Stock Analysis Report National Grid Transco, PLC (NGG) : Free Stock Analysis Report Evergy Inc. (EVRG) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
05-06-2025
- Business
- Yahoo
Nebius Stock Soars 57% in a Month: Time to Hold or Book Profits?
Nebius Group N.V. NBIS shares have gained 57.3% over the past month, outperforming the Zacks Computer & Technology sector and the Zacks Internet Software Services industry's growth of 10.1% and 10.6%, respectively. The S&P 500 Composite is up 6.3% over the same time frame. Image Source: Zacks Investment Research The stock has risen 9.4% since it announced private placement of $1 billion in convertible notes on June 2. NBIS plans to utilize this to boost its global AI infrastructure footprint and drive up revenue opportunities in 2026. Despite the surge, NBIS stock is still trading 22.6% below its 52-week high and closed last trading session at $39.39. Investors are likely to contemplate what to do next, whether it is time to take profits or continue holding NBIS as the rally extends. Nebius posted 385% year-over-year revenue growth in the first quarter of 2025, driven by accelerating demand for its AI infrastructure services. Annualized run-rate revenue or ARR saw a 700% jump, highlighting a structurally expanding revenue base. ARR for April was $310, which provides a strong start for the second quarter. Nebius is carrying strong momentum into the second quarter of 2025 and remains confident in achieving its full-year ARR guidance of $750 million to $1 billion. For 2025, the company also reaffirmed its overall revenue guidance of $500 million to $700 million. Nebius Group N.V. price-consensus-eps-surprise-chart | Nebius Group N.V. Quote To gain a larger share of the AI cloud compute market, NBIS is focusing on technical enhancements that increase reliability and reduce downtime to boost customer retention. In the first quarter, Nebius significantly upgraded its AI cloud infrastructure through improvements to its Slurm-based cluster. These enhancements included automatic recovery for failed nodes and proactive system health checks designed to identify issues before they impact jobs. This directly lowers downtime and boosts capacity availability. According to the company, these changes led to an estimated 5% improvement in the availability of nodes for commercial use. Nebius is making substantial investments in improving its object storage capabilities, and the upgraded storage system ensures that big data sets can be easily accessed and saved quickly during model training, directly lowering time-to-result for end users. NBIS successfully graduated multiple platform services like MLflow and JupyterLab Notebook from beta to general availability. Nebius expanded integrations with external AI platforms like Metaflow, D Stack and SkyPilot, enabling customers to migrate tools with nominal friction. Nebius is deepening ties with industry giants, particularly NVIDIA Corporation NVDA, an investor in the company. Nebius will be one of the first AI cloud infrastructure platforms to offer the NVIDIA Blackwell Ultra AI Factory Platform and become a launch partner for NVIDIA Dynamo. It will also support the DGX Cloud Lepton marketplace at launch, a significant channel expansion opportunity. Nebius is focusing on building a global footprint, with capacity in the United States, Europe, and the Middle East. It added three new regions, including a strategic data center in Israel, in the last reported quarter. Infrastructure enhancement helps reduce latency, diversify risk, and extend support for global customer requirements, which is crucial for enterprise AI workloads. Apart from its core cloud platform, other notable offerings by Nebius include Toloka, an AI development platform; TripleTen, an edtech service; and Avride, an autonomous vehicle platform. NBIS holds stake in Toloka, which is now backed by Amazon's AMZN Jeff Bezos and Shopify's Mikhail Parakhin. This investment marks a key milestone in Toloka's growth, enabling it to scale rapidly and enhance its focus as global demand for high-quality AI data continues to rise. Avride struck partnerships with major players like Uber, Hyundai, GrubHub, and Rakuten in the last reported quarter. NBIS has a 28% stake in ClickHouse, valued at around $6 billion presently. Nonetheless, the intense competition from behemoths remains a concern, along with profitability issues. Nebius is a relatively new entrant in the AI cloud infrastructure space, which boasts behemoths like Amazon, Microsoft MSFT and Alphabet. Amazon Web Services and Microsoft's Azure cloud platform together dominate more than half of the cloud infrastructure services market. Additionally, Microsoft's exclusive partnership with OpenAI gives Azure cloud the priority to access, leading AI models like GPT-4 Turbo and DALL·E. Despite its exceptional top-line growth, NBIS remains unprofitable, with management reaffirming that adjusted EBITDA will be negative for the full year 2025. Though it added that adjusted EBITDA will turn positive at 'some point in the second half of 2025.' NBIS has also raised its 2025 capital expenditure forecast to approximately $2 billion from the previous estimate of $1.5 billion, primarily due to some planned fourth-quarter spending shifting into early first quarter. Higher capex can be a concern if revenue does not keep up the required pace to sustain such high capital intensity. Analysts have significantly revised their earnings estimates downward for NBIS' bottom line over the past 60 days. Image Source: Zacks Investment Research Valuation-wise, NBIS is overvalued, as suggested by the Zacks Value Score of F. In terms of Price/Book, NBIS shares are trading at 2.94X, lower than the Internet Software Services industry's ratio of 4, but it could mean more risk than opportunity. Image Source: Zacks Investment Research Nebius' impressive top-line growth, driven by surging AI infrastructure demand and strong ARR momentum, along with strategic partnerships, especially with NVIDIA, and global expansion efforts, strengthens its long-term positioning. However, the company remains unprofitable with adjusted EBITDA projected to be negative for the full year 2025. Rising capital expenditures and intense competition from cloud giants like Amazon and Microsoft are other headwinds. At present, NBIS carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Inc. (AMZN) : Free Stock Analysis Report Microsoft Corporation (MSFT) : Free Stock Analysis Report NVIDIA Corporation (NVDA) : Free Stock Analysis Report Nebius Group N.V. (NBIS) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
05-06-2025
- Business
- Yahoo
Should You Continue to Hold EXAS Sciences Stock in Your Portfolio?
Exact Sciences Corporation's EXAS efforts to further promote its flagship Cologuard as the standard of care are encouraging. The company plans to transform cancer care by providing patients with valuable insights at every step of their diagnosis and treatment. Additionally, it continues to invest in a pipeline of innovative solutions for every stage of cancer diagnosis. However, unfavorable solvency and mounting costs from macroeconomic pressures raise concerns for EXAS' operations. In the past year, this Zacks Rank #3 (Hold) stock has rallied 23.5% against the 17.1% fall of the industry and the S&P 500 Composite's gain of 11.3%. The globally renowned medical device company boasts a market capitalization of $10.34 billion. It has a long-term earnings growth rate of 29.3% compared with the industry's 21.4%. Additionally, the company's earnings surpassed estimates in three of the trailing four quarters and fell short in another, delivering an average surprise of 48.8%. Strategic Priority Bodes Well: Exact Sciences is pushing Cologuard as the CRC screening benchmark, backed by 16 million test uses over the past decade. In the first quarter of 2025, screening revenues increased 14%, led by broad-based Cologuard growth. Continued success in rescreens, care gap programs and growth in new ordering providers fuels this momentum. Exact Sciences is investing in the leadership team, training and sales force efficiency, as well as simplifying the electronic ordering process to further drive growth. Rescreening patients every three years from age 45 is also expected to contribute. Image Source: Zacks Investment Research Meanwhile, the robust international adoption of Oncotype DX led to 4% year-over-year growth in Precision Oncology revenues. The test, included in all major breast cancer treatment guidelines, helps early-stage breast cancer patients by evaluating the need for chemotherapy and recurrence risk. With about 70% of the eligible patients outside the United States not currently being tested, there still remains a substantial opportunity to grow. Enhancing Customer Experience: The company is currently working to build the best digital infrastructure and diagnostics. This vision has two main elements: first, enabling patients to take a more proactive role in their care. Second, it makes it easy for physicians to order tests, interpret results and personalize medicine by applying real-world evidence and guideline recommendations. The combined strength of Exact Nexus, the company's proprietary technology platform, and EXAS' commercial capabilities is leading to more patients completing Cologuard every three years, supporting the company's goal of making screening a routine practice and also closing the screening gap. The company has identified more than 100 opportunities with payers and health systems to address the care gaps with Cologuard through large, organized screening programs. Advancing New Solutions: In late March 2025, the company launched Cologuard Plus, the most accurate non-invasive CRC screening test reported in studies so far. The test rapidly secured Medicare coverage, pricing and quality measure guideline inclusion. With its enhanced specificity, Cologuard Plus is expected to reduce unnecessary follow-up colonoscopies by up to 40% compared to the original Cologuard test. Subsequent to the quarter's end, Exact Sciences marked another highly anticipated launch with its Oncodetect MRD test. Introduced as a laboratory-developed test (LDT), the company expects to obtain Medicare reimbursement through the Molecular Diagnostic Services Program in the second quarter of 2025. Furthermore, the Cancerguard MCED test is on track to be launched as an LDT later this year. The company is also making headway with its blood-based colon cancer screening test, with top-line results from the pivotal BLUE-C study expected by mid-2025. Strong Solvency but Highly Leveraged: Exact Sciences exited the first quarter of 2025 with cash and cash equivalents and marketable securities of $786 million and zero current debt. However, the company's significant indebtedness is a concern. Long-term debt of $2.32 billion was almost consistent with the fourth-quarter levels. Escalating Costs: Exact Sciences' business has been affected by global macroeconomic conditions. Disruptions in the United States, Europe or other economies, whether from geopolitical tensions or changing international trade policies, could disrupt global markets, interrupt global supply chains and lead to inflationary or recessionary effects on the worldwide economy. In addition, the high-interest rate environment and limited access to capital markets could strain the company's suppliers, distributors and key business partners, making it difficult for them to remain in business. All these are creating significant pressure on its profitability as well. In the past 30 days, the Zacks Consensus Estimate for Exact Sciences' loss for 2025 went from 61 cents to 14 cents in the past 60 days. The Zacks Consensus Estimate for the company's 2025 revenues suggests a 12.4% year-over-year improvement to $3.10 billion. Some better-ranked stocks in the broader medical space are Phibro Animal Health PAHC, Hims & Hers Health HIMS and Cencora COR. Phibro Animal Health has an estimated long-term earnings growth rate of 26% compared with the industry's 15.7%. Its earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters, with the average surprise being 30.6%. Its shares have rallied 37.7% compared with the industry's 10.7% growth in the past year. PAHC sports a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today's Zacks #1 Rank stocks here. Hims & Hers Health, currently carrying a Zacks Rank #2, has an earnings yield of 1.3% against the industry's 11.9% yield. Shares of the company have surged 151.7% compared with the industry's 32.5% gain. HIMS' earnings surpassed estimates in two of the trailing four quarters, matched on one occasion and missed on another, the average surprise being 2.8%. Cencora, carrying a Zacks Rank #2 at present, has an earnings yield of 5.4% compared with the industry's 4.1%. Shares of the company have rallied 25.8% against the industry's 22.4% fall. COR's earnings surpassed estimates in each of the trailing four quarters, with the average surprise being 6%. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Cencora, Inc. (COR) : Free Stock Analysis Report Phibro Animal Health Corporation (PAHC) : Free Stock Analysis Report Exact Sciences Corporation (EXAS) : Free Stock Analysis Report Hims & Hers Health, Inc. (HIMS) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
03-06-2025
- Business
- Yahoo
CRDO Tanks 33% in 3 Months: Should You Hold the Stock or Make an Exit?
Credo Technology Group Holding Ltd CRDO stock has slipped 33.3% over the past three months, significantly more than the Electronic-Semiconductors industry's decline of 16.4%. The broader Computer and Technology sector and S&P 500 Composite have registered declines of 11.5% and 7.8%, respectively, over the same time frame. The markets since April have been affected by evolving U.S. trade policy and diminishing macroeconomic visibility. Image Source: Zacks Investment Research CRDO gained 6.1% yesterday and closed trading at $51.39, but the stock is down 41% below its 52-week high of $86.69. This is likely to spook investors as they contemplate how to strategize their investment now. The natural question is: Should you stay invested or exit now? Let's weigh the pros and cons of this AI stock and see whether it is worth staying invested or not. Credo is a provider of high-performance serial connectivity solutions for the data infrastructure market. Amid exponential data growth and rapid AI proliferation, market demand for faster and energy-efficient connectivity solutions continues to increase. This bodes well for Credo. One of Credo's key strengths lies in its Active Electrical Cables (AEC) product line, which posted triple-digit sequential growth in the third quarter of fiscal 2025. The growth is driven by its increasing adoption in the data center market. The demand for AECs is increasing as ZeroFlap AECs offer more than 100 times improved reliability than laser-based optical solutions. This made AECs an increasingly attractive option for data center applications, contributing to the new expansion of AEC usage and further solidifying Credo Technology's position in the market. Image Source: Zacks Investment Research Credo is also focused on expanding its product portfolio to include a portfolio of PCIe solutions, which will address the growing demand for AI scale-out and scale-up networks. The company expects the PCIe products to considerably expand its total addressable market. This expansion into PCIe connectivity further solidifies the company's competitive positioning in the high-performance computing and AI markets. Momentum in the optical business, particularly for Optical Digital Signal Processors (DSPs), bodes well. In April 2025, CRDO unveiled the innovative Lark Optical DSP family, engineered to transform 800G optical transceivers. The Lark portfolio has two distinct optical DSP products. The Lark 800 is a high-performance, low-power DSP optimized for fully retimed 800G transceivers, designed to meet the stringent power and cooling requirements of hyperscale AI data centers. The Lark 850 is an ultra-low-power 800G Linear Receive Optics DSP, consuming under 10W, making it an ideal solution for AI-driven data environments where power efficiency is exceptional. CRDO's PCIe retimers and Ethernet retimers saw strong customer interest, especially for scale-out networks in AI servers. This growing demand underscores the increasing importance of high-performance solutions in the rapidly expanding AI server market. PCIe retimer demand is expected to exceed $1 billion by 2027, positioning Credo Technology for significant future revenue growth. For the fourth quarter of fiscal 2025, CRDO expects revenues between $155 million and $165 million. The Zacks Consensus Estimate for fiscal fourth-quarter revenues is pegged at $160 million, suggesting growth of 163.2% from the year-ago quarter's reported figure. For the third quarter of fiscal 2025, CRDO reported $135 million in revenues, up 87% sequentially and 154% year over year, beating the Zacks Consensus Estimate by 12.5%. This surge was mainly driven by its largest hyperscale customer, which significantly scaled the production of AI platforms, reflecting the growing demand for AI-powered connectivity solutions. Despite Credo's strong performance and innovative solutions, several challenges pose headwinds to its prospects. CRDO's business is heavily tilted toward AI-related infrastructure and the hyperscale cloud market spending. While these segments are currently experiencing high growth, they are also cyclically dependent on AI capex spending, which could decelerate after initial buildouts. Credo's non-GAAP operating expenses in the fiscal third quarter surged 16% sequentially to $43.8 million, primarily due to higher headcount. Increasing costs could become a problem if the revenue growth does not keep pace. In the last reported quarter, 86% of revenue came from a single end customer. This intense customer concentration risk can impact revenues as the company becomes highly vulnerable to the loss of business from those clients. To diversify its base, CRDO added that it has two additional hyperscalers in qualification and has already achieved volume production with three others. The company expects to ramp up with these two hyperscalers in fiscal 2026. These factors, along with increasing market competition and macroeconomic uncertainties, may impact CRDO's growth trajectory. Credo competes with semiconductor giants like Broadcom Inc. AVGO and Marvell Technology, Inc. MRVL. Analysts also seem wary as reflected in unchanged revisions for earnings estimates in the past 60 days. Image Source: Zacks Investment Research CRDO's 33.3% decline is also much steeper than peers like Broadcom and Cirrus Logic, Inc. CRUS. Broadcom and Cirrus Logic have declined 11.6% and 6.5%, respectively. However, Marvell's stock has declined 48.9% in the same time frame. Credo Technology stock is also not so cheap, as its Value Style Score of F suggests a stretched valuation at this moment. In terms of the forward 12-month Price/Sales ratio, CRDO is trading at 12.92, higher than the Electronic-Semiconductors sector's multiple of 6.97. Image Source: Zacks Investment Research In comparison, Broadcom trades at a forward 12-month P/S multiple of 14.46, while Cirrus Logic and Marvell Technology are trading at a multiple of 2.76 and 5.71, respectively. While Credo appears well-positioned in the AI-driven connectivity space, there are several factors that could exert downward pressure on the stock. Key concerns include customer concentration, competitive pressures, stretched valuation, and overreliance on AI spending. CRDO currently carries a Zacks Rank #3 (Hold), which indicates that investors should wait for a better entry point. However, existing investors can hold the stock as its growth prospects remain intact. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Marvell Technology, Inc. (MRVL) : Free Stock Analysis Report Broadcom Inc. (AVGO) : Free Stock Analysis Report Cirrus Logic, Inc. (CRUS) : Free Stock Analysis Report Credo Technology Group Holding Ltd. (CRDO) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
